Cargando…
CXCL1 promotes colon cancer progression through activation of NF-κB/P300 signaling pathway
BACKGROUND: The upregulated expression of CXCL1 has been validated in colorectal cancer patients. As a potential biotherapeutic target for colorectal cancer, the mechanism by which CXCL1 affects the development of colorectal cancer is not clear. METHODS: Expression data of CXCL1 in colorectal cancer...
Autores principales: | Zhuo, Changhua, Ruan, Qiang, Zhao, Xiangqian, Shen, Yangkun, Lin, Ruirong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701058/ https://www.ncbi.nlm.nih.gov/pubmed/36434686 http://dx.doi.org/10.1186/s13062-022-00348-4 |
Ejemplares similares
-
Lnc-SNHG5 Promoted Hepatocellular Carcinoma Progression Through the RPS3-NFκB Pathway
por: Hao, Jie, et al.
Publicado: (2023) -
CXCL5/NF-κB Pathway as a Therapeutic Target in Hepatocellular Carcinoma Treatment
por: Jia, Xingqing, et al.
Publicado: (2021) -
CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer
por: Chen, Chun, et al.
Publicado: (2019) -
MGP Promotes Colon Cancer Proliferation by Activating the NF-κB Pathway through Upregulation of the Calcium Signaling Pathway
por: Li, Xueqing, et al.
Publicado: (2020) -
Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB–Mediated Production of CXCL1
por: Kemp, Samantha B., et al.
Publicado: (2021)